scPharmaceuticals Inc. Prices 6.4M Share IPO at $14/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
November 16, 2017 9:05 PM ESTBURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the Company) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs, today announced the pricing of its initial public offering of 6,400,000 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts and commissions, for gross proceeds of $89.6 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public offering price, less the underwriting... More



